Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function

International Journal of Cardiology

Volumn 169, Issue 5, 2013, Pages

  Patel, Nileshkumar J ^a   Hoosien, Michael ^b   Deshmukh, Abhishek ^c   Badheka, Apurva O ^h   Grover, Peeyush M ^b   Shah, Neeraj ^a   Singh, Vikas ^b   Mehta, Kathan ^d   Chothani, Ankit ^e   Savani, Ghanshyambhai T ^b   Arora, Shilpkumar ^g   Bhalara, Vipulkumar ^h   Patel, Nilay ^h   Khalpada, Dhaval ^h   Rathod, Ankit ^f   Vazzana, Thomas J ^a   Lafferty, James ^a   Viles Gonzalez, Juan F ^a   Mitrani, Raul D ^b  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI HOSPITAL   (United States)

^c UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^d DREXEL UNIVERSITY   (United States)

^e WASHINGTON HOSPITAL CENTER   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h DETROIT MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Digoxin; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; SOTALOL; WARFARIN;

AGED; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; POST HOC ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DIGOXIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84887992177     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.040     Document Type: Article

References (11)

1. J.P. Piccini, B.G. Hammill, and M.F. Sinner Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007 Circ Cardiovasc Qual Outcomes 5 2012 85 93
2. W.G. Stevenson, and C.M. Albert Catheter ablation for paroxysmal atrial fibrillation N Engl J Med 367 2012 1648 1649
3. W.G. Stevenson, and L.W. Stevenson Atrial fibrillation and heart failure-five more years N Engl J Med 351 2004 2437 2440
4. D. Roy, M. Talajic, and S. Nattel Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677
5. D.G. Wyse, A.L. Waldo, and J.P. DiMarco Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
6. J.L. Anderson, J.L. Halperin, and N.M. Albert Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations): A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 1935 1944
7. S.D. Corley, A.E. Epstein, and J.P. DiMarco AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513
8. M.G. Whitbeck, R.J. Charnigo, and P. Khairy Increased mortality among patients taking digoxin-analysis from the AFFIRM study Eur Heart J 34 2013 1481 1488
9. M. Gheorghiade, G.C. Fonarow, and D.J. van Veldhuisen Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial Eur Heart J 34 2013 1489 1497
10. S.A. Murphy When 'digoxin use' is not the same as 'digoxin use': lessons from the AFFIRM trial Eur Heart J 34 2013 1465 1467
11. D. Castagno, M.C. Petrie, B. Claggett, and J. McMurray Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure Eur Heart J 33 2012 1137 1141